Perioperative cefazolin prophylaxis in hip fracture surgery

Area of Science:

• Orthopedic Surgery
• Infectious Diseases
• Clinical Pharmacology

Background:

• Perioperative antibiotics are standard for reducing postoperative wound infections.
• Current antibiotic duration protocols for hip fracture surgery lack definitive evidence and are often empirical.
• Postoperative wound infections pose a significant risk following hip fracture surgery.

Purpose of the Study:

• To evaluate the impact of antibiotic prophylaxis duration on surgical site infections after hip fracture repair.
• To compare infection rates between patients receiving one dose, four doses of cefazolin, or placebo.
• To determine if a multi-dose antibiotic regimen offers benefits over a single dose or no antibiotics.

Main Methods:

• A randomized, double-blind, single-hospital clinical trial.
• Three patient groups were compared: four doses of cefazolin (n=108), one dose of cefazolin plus three placebo doses (n=83), and four placebo doses (n=121).
• Wound infection rates were the primary outcome measure.

Main Results:

• Surgical wound infection rates were 1.6% (four-dose group), 2.4% (one-dose group), and 3.7% (placebo group).
• The observed differences in infection rates among the three groups were not statistically significant.
• Combining the antibiotic treatment groups and comparing them to the placebo group also yielded no statistically significant difference.

Conclusions:

• The study did not demonstrate a statistically significant benefit of multi-dose cefazolin over single-dose or placebo for preventing wound infections in hip fracture surgery.
• Current empirical antibiotic prophylaxis practices for hip fracture surgery should be maintained.
• Further research with a larger patient cohort is recommended to definitively assess the efficacy of different antibiotic durations.